Gedeon Richter licenses technology from Crucell and DSM
This article was originally published in Scrip
Gedeon Richterhas signed a biopharmaceuticals licence agreement with DSM Biologics, part of DSM Pharmaceutical Products, and the Dutch biotechnological companyCrucell. The agreement enables Hungary's largest pharmaceutical company to produce certain products using a technology for which the two companies have co-exclusive licensing rights. Other terms of the agreement have not been disclosed.